ES2096771T3 - Utilizacion de soluciones acuosas que contienen iones de peroxodisulfato para el tratamiento de celulas malignas. - Google Patents

Utilizacion de soluciones acuosas que contienen iones de peroxodisulfato para el tratamiento de celulas malignas.

Info

Publication number
ES2096771T3
ES2096771T3 ES92920642T ES92920642T ES2096771T3 ES 2096771 T3 ES2096771 T3 ES 2096771T3 ES 92920642 T ES92920642 T ES 92920642T ES 92920642 T ES92920642 T ES 92920642T ES 2096771 T3 ES2096771 T3 ES 2096771T3
Authority
ES
Spain
Prior art keywords
aqueous solutions
treatment
malignant cells
solutions containing
ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920642T
Other languages
English (en)
Inventor
Aloys Renschler
Dieter Schuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2096771T3 publication Critical patent/ES2096771T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1028—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy using radiation sources applied onto the body
    • A61N5/1029—Radioactive dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Solid Wastes (AREA)
  • External Artificial Organs (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE SOLUCIONES ACUOSAS QUE CONTIENEN IONES PEROXOBISULFATO PARA LA ELABORACION DE MEDICAMENTOS EN EL TRATAMIENTO DE CELULAS MALIGNAS DEL CUERPO HUMANO Y DE ANIMALES. SE DESCRIBE ADEMAS UN PROCEDIMIENTO PARA LA ELABORACION DE LOS MEDICAMENTOS, Y UN DISPOSITIVO PARA LA REALIZACION DEL PROCEDIMIENTO. LOS MEDICAMENTOS SON OBTENIBLES POR EJEMPLO A TRAVES DE RADIACION ACTINICA DE SOLUCIONES ACUOSAS, QUE CONTIENEN ANIONES DE OXO-ACIDO SULFURICO, EN PARTICULAR IONES SULFATO Y/O IONES PEROXOBISULFATO, SIENDO EL VALOR PH ENTRE 2 Y 7.
ES92920642T 1992-01-24 1992-09-29 Utilizacion de soluciones acuosas que contienen iones de peroxodisulfato para el tratamiento de celulas malignas. Expired - Lifetime ES2096771T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4201858A DE4201858A1 (de) 1992-01-24 1992-01-24 Mittel zur behandlung maligner zellen

Publications (1)

Publication Number Publication Date
ES2096771T3 true ES2096771T3 (es) 1997-03-16

Family

ID=6450147

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920642T Expired - Lifetime ES2096771T3 (es) 1992-01-24 1992-09-29 Utilizacion de soluciones acuosas que contienen iones de peroxodisulfato para el tratamiento de celulas malignas.

Country Status (15)

Country Link
US (1) US5603962A (es)
EP (1) EP0621785B1 (es)
JP (1) JPH07505615A (es)
KR (1) KR950700074A (es)
AT (1) ATE145826T1 (es)
AU (1) AU676996B2 (es)
CA (1) CA2128728A1 (es)
DE (2) DE4201858A1 (es)
DK (1) DK0621785T3 (es)
ES (1) ES2096771T3 (es)
FI (1) FI943479A0 (es)
GR (1) GR3022054T3 (es)
HU (1) HUT71319A (es)
NO (1) NO942723L (es)
WO (1) WO1993014774A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE887320A (fr) * 1975-07-07 1981-05-14 Solomides Fortune Nee Chetboun Composition et medicament anti-inflammatoire qui comprend une telle composition
DK168191B1 (da) * 1984-06-27 1994-02-28 Colgate Palmolive Co Anvendelse af peroxydiphosphater til fremstilling af farmaceutiske tabletter eller farmaceutiske vandige opløsninger
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
US4744968A (en) * 1985-09-03 1988-05-17 Technicon Instruments Corporation Stabilized aqueous hydrogen peroxide solution

Also Published As

Publication number Publication date
FI943479A7 (fi) 1994-07-22
DE4201858A1 (de) 1993-07-29
US5603962A (en) 1997-02-18
HU9402176D0 (en) 1994-10-28
ATE145826T1 (de) 1996-12-15
JPH07505615A (ja) 1995-06-22
HUT71319A (en) 1995-11-28
WO1993014774A1 (de) 1993-08-05
FI943479L (fi) 1994-07-22
AU676996B2 (en) 1997-04-10
NO942723D0 (no) 1994-07-20
NO942723L (no) 1994-07-20
DE59207635D1 (de) 1997-01-16
EP0621785A1 (de) 1994-11-02
KR950700074A (ko) 1995-01-16
DK0621785T3 (da) 1997-06-02
GR3022054T3 (en) 1997-03-31
FI943479A0 (fi) 1994-07-22
CA2128728A1 (en) 1993-08-05
AU2651692A (en) 1993-09-01
EP0621785B1 (de) 1996-12-04

Similar Documents

Publication Publication Date Title
ATE30575T1 (de) Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten.
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ES2058547T3 (es) Fuente organica de fluoruro.
ES8305582A1 (es) Metodo para producir una composicion medicinal que comprende un gel acuoso reabsorbible de proteina fibrosa y agente an-tibacteriano de transferencia de metilol.
ZA200101244B (en) Skin and tissue care and/or treatment agent.
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
ES2042532T3 (es) Procedimiento para preparar un agente destinado a la terapia o profilaxis de trastornos hemostaticos.
ES8702145A1 (es) Procedimiento para la preparacion de un polvo para heridas, libremente fluyente, homogeneo, conteniendo yodoforo
ES8306363A1 (es) "procedimiento para la preparacion de composiciones de ferormonas aldehidicas de lenta liberacion del compuesto activo".
MX9304636A (es) Metodos de tratamiento terapeutico y anestesico y preparaciones para ellos.
WO1993014741A3 (de) Haar- und körperbehandlungsmittel
AU616657B2 (en) Butyl hydroxyanisoles for the treatment of retroviral diseases
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
ES8704738A1 (es) Procedimiento para estabilizar y-0 aumentar el efecto microbicida de soluciones acuosas de h2o2
ES2056975T3 (es) Proceso para separar sales contenidas en el agua de mar.
ES2165034T3 (es) Agentes terapeuticos que contienen ebselen contra el asma.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ES2042724T3 (es) Una composicion terapeutica o profilactica.
ES2031254T3 (es) Procedimiento de inmovilizacion, mediante un ligante hidraulico, de resinas intercambiadoras de iones radiactivos.
ES2103811T3 (es) Terapia antiviral.
NO942723D0 (no) Anvendelse av vanndige lösninger som inneholder peroksodisulfationer til behandling av ondartede celler
GR77250B (es)
SU1697314A1 (ru) Средство для профилактики спаечной болезни "изонидез"
JPS6461419A (en) Allithiamine-containing agent for external use
BG101323A (en) Antiseptic means

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621785

Country of ref document: ES